U.S. flag

An official website of the United States government

NM_181882.3(PRX):c.3685C>T (p.Arg1229Ter) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 7, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003221503.1

Allele description [Variation Report for NM_181882.3(PRX):c.3685C>T (p.Arg1229Ter)]

NM_181882.3(PRX):c.3685C>T (p.Arg1229Ter)

Gene:
PRX:periaxin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_181882.3(PRX):c.3685C>T (p.Arg1229Ter)
HGVS:
  • NC_000019.10:g.40394667G>A
  • NG_007979.1:g.23698C>T
  • NG_051224.1:g.555C>T
  • NM_001411127.1:c.3970C>T
  • NM_020956.2:c.*3890C>T
  • NM_181882.3:c.3685C>TMANE SELECT
  • NP_001398056.1:p.Arg1324Ter
  • NP_870998.2:p.Arg1229Ter
  • NP_870998.2:p.Arg1229Ter
  • LRG_265t1:c.*3890C>T
  • LRG_265t2:c.3685C>T
  • LRG_265:g.23698C>T
  • LRG_265p2:p.Arg1229Ter
  • NC_000019.9:g.40900574G>A
  • NM_181882.2:c.3685C>T
Protein change:
R1229*
Molecular consequence:
  • NM_020956.2:c.*3890C>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001411127.1:c.3970C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_181882.3:c.3685C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003918276GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Likely pathogenic
(Oct 7, 2022)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV003918276.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Reported previously in a patient with childhood-onset demyelinating CMT who also harbored a second variant in the gene (phase unknown) (Machado et al., 2022); Reported previously as a pathogenic variant in a cohort of individuals referred for genetic testing for Charcot-Marie-Tooth disease; however, no clinical information was provided (DiVincenzo et al., 2014); Nonsense variant predicted to result in protein truncation, as the last 233 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28641335, 25614874, Machado2022[CaseReport])

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2023